Andrea Polari
Overview
Explore the profile of Andrea Polari including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
45
Citations
288
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lo Buglio G, Mirabella M, Muzi L, Boldrini T, Cerasti E, Bjornestad J, et al.
Eat Weight Disord
. 2024 Dec;
29(1):78.
PMID: 39729192
Background: Eating disorders (EDs) are among the least studied mental disorders in individuals at clinical high risk for psychosis (CHR-P). The primary aim (a) of this systematic review and meta-analysis...
2.
Wannan C, Scott I, Dwyer D, Clark S, Hartmann S, Ye R, et al.
Schizophr Bull
. 2024 Dec;
PMID: 39707153
Background: Almost 40% of individuals at ultra-high risk (UHR) for psychosis experience persistent attenuated psychotic symptoms (APS) yet it is unclear (1) whether they share overlapping clinical and functional outcomes...
3.
Boldrini T, Lo Buglio G, Lomoriello A, Barsanti A, Cordova E, De Salve F, et al.
Asian J Psychiatr
. 2024 Oct;
102:104254.
PMID: 39393161
Aims: The current range of labeling terms-at-risk mental state (ARMS), ultra-high risk for psychosis (UHR), and attenuated psychotic syndrome (APS)-used to refer to the psychosis-risk concept is varied, and their...
4.
Moller P, Nelson B, McGorry P, Mei C, Amminger G, Yuen H, et al.
Schizophr Bull
. 2024 Sep;
PMID: 39241740
Background: Since the late 1990s, there has been a worldwide surge of scientific interest in the pre-psychotic phase, resulting in the introduction of several clinical tools for early detection. The...
5.
Nelson B, Yuen H, Amminger G, Berger G, Chen E, de Haan L, et al.
Schizophr Bull Open
. 2024 Aug;
3(1):sgaa006.
PMID: 39144772
This study examined whether distress in relation to attenuated psychotic symptoms (DAPS) is associated with clinical outcomes in an ultra-high risk (UHR) for psychosis sample. We also investigated whether DAPS...
6.
Gates J, Ellinghaus C, Valentine L, Kamitsis I, Stainton A, Harrigan S, et al.
Psychiatr Rehabil J
. 2024 Jul;
47(4):313-321.
PMID: 39023955
Objective: The current guidelines recommend continuation of antipsychotic medication for a minimum of at least 1 year following a first episode of psychosis (FEP). There have been several trials investigating...
7.
Lo Buglio G, Boldrini T, Polari A, Fiorentino F, Nelson B, Solmi M, et al.
Front Psychol
. 2024 Jul;
15:1381864.
PMID: 38966724
Aims: To map studies assessing both clinical high risk for psychosis (CHR-P) and borderline personality disorder (BPD) in clinical samples, focusing on clinical/research/preventive paradigms and proposing informed research recommendations. Methods:...
8.
Boldrini T, Lo Buglio G, Cerasti E, Pontillo M, Muzi L, Salcuni S, et al.
Eur Child Adolesc Psychiatry
. 2024 Jun;
34(1):287-296.
PMID: 38896144
To be relevant to healthcare systems, the clinical high risk for psychosis (CHR-P) concept should denote a specific (i.e., unique) clinical population and provide useful information to guide the choice...
9.
Collins M, Bartholomeusz C, Mei C, Kerr M, Spark J, Wallis N, et al.
Psychiatry Res
. 2024 May;
337:115966.
PMID: 38810536
Decreased white matter (WM) integrity and disturbance in fatty acid composition have been reported in individuals at ultra-high risk of psychosis (UHR). The current study is the first to investigate...
10.
Takahashi T, Katagiri N, Higuchi Y, Nishiyama S, Arai Y, Tagata H, et al.
Schizophr Res
. 2024 Apr;
267:373-380.
PMID: 38631112
Background: Labeling terms for high-risk state for psychosis, such as 'ultra-high risk' (UHR), 'attenuated psychosis syndrome' (APS), and 'at-risk mental state' (ARMS), have been criticized for their potential to lead...